Appoints Frederik Decouttere as CEO LAUSANNE, Switzerland — Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round with an additional CHF 3 million ($3.9 million), led by Genku Ventures and joined by Novalis Biotech and Zürcher Kantonalbank as well as several […]
mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive detection of cancer, chronic disease, and in basic research Launch follows successful close of oversubscribed $15.5 million seed financing led by ARCH Venture Partners Gautam Kollu, former CCO of Grail, joins Board Syndex […]
STOCKHOLM, Sweden — CubaseBio, a biotechnology company founded by pioneers in spatial biology, today announced it has secured €5.9 million in blended financing. The funding comprises a €2 million non-dilutive grant from the European Innovation Council (EIC) Transition program and €3.9 million in private capital and convertibles from Voima Ventures, Nordic Science Investments (NSI), Illumina Ventures, Almi invest, Life Science Invest and […]
TeraView, the pioneer and leader in terahertz technology and solutions, is the first UK and European-based company to list on KOSDAQ, the secondary Korean stock market for small to medium-sized (SME) high-growth, technology and venture companies. TeraView listed on December 9 and supports companies such as NVIDIA, AMD, Intel, Samsung, Ford, Volkswagen and other major […]
New funding accelerates platform development and meets surging demand as pharma and biotech reimagine drug discovery LONDON — Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus […]
Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up Cambridge / Edinburgh, UK: Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 million (£2.1 […]
Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh The funding will accelerate development of eProtein Discovery for full-format antibody expression, purification, and binding validation Cambridge, UK, and Boston MA, USA: Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins […]
HOLLYWOOD, Fla. — StarLIMS, a global enterprise informatics platform for laboratories, today announced a strategic investment by Turn/River Capital, a leading software private equity firm. Existing investor Francisco Partners will exit its investment as a result of this transaction. StarLIMS powers manufacturing and research lab operations worldwide. The company enables greater data automation and visibility, […]
Additional funding of $20 million accelerates commercialization of Trailhead’s iPSC-derived human cell and media products. BEACHWOOD, Ohio and CAMBRIDGE, Mass. — Trailhead Biosystems Inc. (www.trailbio.com), a biotechnology company advancing human cell innovation, has added $20 million in new funding, expanding the financing announced in May 2025 to $40 million. The funding extension was led by […]
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors Fremont, Calif. – Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
